404

    Page Not Found

    The page you're looking for doesn't exist or has been moved.

    Medically Reviewed

    TMRT

    Trimi Medical Review Team

    Clinical review workflow for GLP-1 safety, dosing, and access content

    Team-based medical review process documented in Trimi's Medical Review Policy

    Last reviewed: June 24, 2025

    TCCT

    Written by Trimi Clinical Content Team

    Medical Writers & Healthcare Professionals

    Our clinical content team includes registered nurses, pharmacists, and medical writers who specialize in translating complex medical information into clear, actionable guidance for patients.

    Editorial Standards

    Trimi publishes patient education using a medical-review workflow, source-based claim checks, and dated updates for fast-changing pricing, access, and safety topics.

    Review our Editorial Policy and Medical Review Policy for more details about sourcing, updates, and reviewer attribution.

    Was this article helpful?

    Keep Reading

    Detailed comparison of retatrutide vs tirzepatide: 24.2% vs 22.5% weight loss, mechanism differences, side effects, cost projections, and whether to wait or start now.

    Side-by-side comparison of retatrutide, tirzepatide, and semaglutide: mechanisms, weight loss data, side effects, dosing, cost, and availability in 2026.

    Combining metformin with semaglutide or tirzepatide is increasingly common. Learn the clinical evidence, dosing considerations, and which patients benefit most.

    Many GLP-1 patients also take antidepressants. Learn about interactions between semaglutide or tirzepatide and SSRIs, SNRIs, and bupropion.